Lenvatinib Liposome (CAT#: LDLY-0724-LD88)

Description
Lenvatinib is a type I tyrosine kinase inhibitor that exhibits potent anti-angiogenic activity in cancer therapy. This product is a pre-formulated liposome encapsulating Lenvatinib. It is only for research purposes.
Lipid Composition
HSPC, Cholesterol
Encapsulated Drug
Lenvatinib
Buffer
CPBS, pH 3.0
Storage
Store in dark at +4°C and do not freeze
Size
100-200 nm
Quantity
5mL (available in lyophilized powder)
Download
DataSheet MSDS
Customer Reviews Related Sections

Click the button below to contact us or submit your feedback about this product.

For Research Use Only. Not For Clinical Use

Online Inquiry

Advertisement